OTC
Strength
60 mg/1
Manufacturer
Haleon US Holdings LLCNDC
00135046105
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
3/18/2020
Active Ingredients
ORLISTATApproval Type
New Drug (NDA)
FDA Application
NDA021887On Market Since
2/7/2007
Pharmacological Classes
Intestinal Lipase Inhibitor
Lipase Inhibitors
Related Drugs
Same classification
No related drugs found.